| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |